{
    "eid": "2-s2.0-85131442682",
    "title": "Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biotechnology",
            "@code": "1305",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Biophysics",
            "@code": "1304",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Structural Biology",
            "@code": "1315",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Genetics",
            "@code": "1311",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Computer Science Applications",
            "@code": "1706",
            "@abbrev": "COMP"
        }
    ],
    "keywords": [
        "Andrographolide analogues",
        "COVID-19",
        "Drug discovery",
        "Enzyme-based assay",
        "MD simulations",
        "Molecular docking",
        "SARS-CoV-2 main protease"
    ],
    "authors": [
        "Bodee Nutho",
        "Patcharin Wilasluck",
        "Peerapon Deetanya",
        "Kittikhun Wangkanont",
        "Patcharee Arsakhant",
        "Rungnapha Saeeng",
        "Thanyada Rungrotmongkol"
    ],
    "citedby-count": 1,
    "ref-count": 84,
    "ref-list": [
        "Origin and evolution of pathogenic coronaviruses",
        "Evidence for gastrointestinal infection of SARS-CoV-2",
        "Organ-specific manifestations of COVID-19 infection",
        "On the whereabouts of SARS-CoV-2 in the human body: A systematic review",
        "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
        "A Comprehensive review of the global efforts on COVID-19 vaccine development",
        "The biological and clinical significance of emerging SARS-CoV-2 variants",
        "Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic",
        "A new coronavirus associated with human respiratory disease in China",
        "Emerging coronaviruses: Genome structure, replication, and pathogenesis",
        "Coronavirus biology and replication: implications for SARS-CoV-2",
        "The SARS-CoV-2 main protease as drug target",
        "Progress in developing inhibitors of SARS-CoV-2 3C-like protease",
        "Structure of Mprofrom SARS-CoV-2 and discovery of its inhibitors",
        "Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease",
        "Structural plasticity of SARS-CoV-2 3CL Mproactive site cavity revealed by room temperature X-ray crystallography",
        "Targeting the dimerization of the main protease of coronaviruses: A potential broad-spectrum therapeutic strategy",
        "Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors",
        "Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease",
        "Natural products as sources of new drugs from 1981 to 2014",
        "Andrographolide, a natural antioxidant: An update",
        "Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide",
        "Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide",
        "Broad-spectrum antiviral properties of andrographolide",
        "Andrographis paniculata in the treatment of upper respiratory tract infections: A systematic review of safety and efficacy",
        "Andrographis paniculata (Burm. f.) wall. ex nees: An updated review of phytochemistry, antimicrobial pharmacology, and clinical safety and efficacy",
        "Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach",
        "Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach",
        "Active compounds activity from the medicinal plants against SARS-CoV-2 using in silico assay",
        "Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials",
        "Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage",
        "Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives",
        "Polypharmacology of andrographolide: Beyond one molecule one target",
        "The modification of natural products for medical use",
        "Design and synthesis of C-12 dithiocarbamate andrographolide analogues as an anticancer agent",
        "Interaction of 8-anilinonaphthalene-1-sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification",
        "Production of authentic SARS-CoV Mprowith enhanced activity: Application as a novel tag-cleavage endopeptidase for protein overproduction",
        "Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction",
        "Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms",
        "3.0: Automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations",
        "Unraveling the SARS-CoV-2 main protease mechanism using multiscale methods",
        "Gaussian 09",
        "Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics",
        "Structural basis of specific glucoimidazole and mannoimidazole binding by Os3BGlu7",
        "Development and testing of a general Amber force field",
        "FF19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution",
        "Software news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading",
        "Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility",
        "Building water models: A different approach",
        "An overview of the Amber biomolecular simulation package",
        "Particle mesh Ewald: An N\u00b7log(N) method for Ewald sums in large systems",
        "Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes",
        "Molecular dynamics with coupling to an external bath",
        "Synchronization of trajectories in canonical molecular-dynamics simulations: Observation, explanation, and exploitation",
        "PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data",
        "MMPBSA.py: An efficient program for end-state free energy calculations",
        "Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses",
        "\u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: Structure-based design, synthesis, and activity assessment",
        "Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds",
        "Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor",
        "Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mproand cathepsin L",
        "Benchmarking the ability of common docking programs to correctly reproduce and score binding modes in SARS-CoV-2 protease Mpro",
        "Strengths and weaknesses of docking simulations in the SARS-CoV-2 era: The main protease (Mpro) case study",
        "Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition",
        "Exploring protein native states and large-scale conformational changes with a modified generalized Born model",
        "Accurate calculation of hydration free energies using macroscopic solvent models",
        "Harmonic dynamics of proteins: Normal modes and fluctuations in bovine pancreatic trypsin inhibitor",
        "Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease",
        "Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation",
        "Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica molecular dynamics simulations",
        "Computational determination of potential inhibitors of SARS-CoV-2 main protease",
        "Comparison of radii sets, entropy, QM methods, and sampling on MM-PBSA, MM-GBSA, and QM/MM-GBSA ligand binding energies of F. tularensis enoyl-ACP reductase (FabI)",
        "Both boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease",
        "Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies",
        "Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease",
        "Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a inhibitors: In silico modeling and in vitro screening",
        "What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design",
        "Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors",
        "Clinical development success rates for investigational drugs",
        "Exploring the binding mechanism of PF-07321332 SARS-CoV-2 protease inhibitor through molecular dynamics and binding free energy simulations",
        "Halogenated baicalein as a promising antiviral agent toward SARS-CoV-2 main protease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chonburi",
            "@id": "60009116",
            "affilname": "Burapha University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009116",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Thailand Science Research and Innovation Fund Chulalongkorn University",
        "Chulalongkorn University",
        "Mahidol University",
        "Agricultural Research Development Agency"
    ]
}